Abstract
Recent studies have shown that there is a direct association between a Th1-related immune response and a better prognosis in patients with cancer. These findings have led us to hypothesize that the protective Th1-type immune response toward cancer might be inhibited by immunoregulatory factors. One example is ST2L, which when activated by the cytokine IL-33 promotes Th2-type responses and…